A new study published by the Journal on Aging & Disease reports that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease 2019 (COVID19) resulted in improved functional outcomes (Leng et al., Aging Dis, 11:216-228, 2020). This study demonstrated that intravenous infusion of MSCs is a safe and effective approach...Read More
Peer-Reviewed Publications
Looking for more information about regenerative treatments & Regenerative Cell Therapy? We’ve compiled a list of peer-reviewed publications organized by joint, injury, disease & treatment.
